These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37324436)

  • 61. Bioengineered Carboxymethylcellulose-Peptide Hybrid Nanozyme Cascade for Targeted Intracellular Biocatalytic-Magnetothermal Therapy of Brain Cancer Cells.
    Mansur AAP; Carvalho SM; Oliveira LCA; Souza-Fagundes EM; Lobato ZIP; Leite MF; Mansur HS
    Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297660
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A cobalt-doped iron oxide nanozyme as a highly active peroxidase for renal tumor catalytic therapy.
    Wang Y; Li H; Guo L; Jiang Q; Liu F
    RSC Adv; 2019 Jun; 9(33):18815-18822. PubMed ID: 35516849
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Proanthocyanidins exert a neuroprotective effect via ROS/JNK signaling in MPTP‑induced Parkinson's disease models in vitro and in vivo.
    Chen H; Xu J; Lv Y; He P; Liu C; Jiao J; Li S; Mao X; Xue X
    Mol Med Rep; 2018 Dec; 18(6):4913-4921. PubMed ID: 30272275
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Natural Products as the Potential to Improve Alzheimer's and Parkinson's Disease.
    Kim SW; Lee JH; Kim B; Yang G; Kim JU
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240173
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Oxidative Stress: A Key Modulator in Neurodegenerative Diseases.
    Singh A; Kukreti R; Saso L; Kukreti S
    Molecules; 2019 Apr; 24(8):. PubMed ID: 31013638
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Catalytic patch with redox Cr/CeO
    Zhang S; Liu Y; Sun S; Wang J; Li Q; Yan R; Gao Y; Liu H; Liu S; Hao W; Dai H; Liu C; Sun Y; Long W; Mu X; Zhang XD
    Theranostics; 2021; 11(6):2806-2821. PubMed ID: 33456574
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A novel approach for the prevention of ionizing radiation-induced bone loss using a designer multifunctional cerium oxide nanozyme.
    Wei F; Neal CJ; Sakthivel TS; Fu Y; Omer M; Adhikary A; Ward S; Ta KM; Moxon S; Molinari M; Asiatico J; Kinzel M; Yarmolenko SN; San Cheong V; Orlovskaya N; Ghosh R; Seal S; Coathup M
    Bioact Mater; 2023 Mar; 21():547-565. PubMed ID: 36185749
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Monoterpenoid Epoxidiol Ameliorates the Pathological Phenotypes of the Rotenone-Induced Parkinson's Disease Model by Alleviating Mitochondrial Dysfunction.
    Aleksandrova Y; Chaprov K; Podturkina A; Ardashov O; Yandulova E; Volcho K; Salakhutdinov N; Neganova M
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982914
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Flavonoids, the Family of Plant-Derived Antioxidants Making Inroads into Novel Therapeutic Design Against Ionizing Radiation-Induced Oxidative Stress in Parkinson's Disease.
    Behl T; Kaur G; Sehgal A; Zengin G; Singh S; Ahmadi A; Bungau S
    Curr Neuropharmacol; 2022; 20(2):324-343. PubMed ID: 34030619
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Monoamine Oxidase-B (MAO-B) Inhibitors in the Treatment of Alzheimer's and Parkinson's Disease.
    Özdemir Z; Alagöz MA; Bahçecioğlu ÖF; Gök S
    Curr Med Chem; 2021; 28(29):6045-6065. PubMed ID: 33538661
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Ceria Nanoparticle Systems for Selective Scavenging of Mitochondrial, Intracellular, and Extracellular Reactive Oxygen Species in Parkinson's Disease.
    Kwon HJ; Kim D; Seo K; Kim YG; Han SI; Kang T; Soh M; Hyeon T
    Angew Chem Int Ed Engl; 2018 Jul; 57(30):9408-9412. PubMed ID: 29862623
    [TBL] [Abstract][Full Text] [Related]  

  • 72. From regenerative strategies to pharmacological approaches: can we fine-tune treatment for Parkinson's disease?
    Silva RC; Domingues HS; Salgado AJ; Teixeira FG
    Neural Regen Res; 2022 May; 17(5):933-936. PubMed ID: 34558504
    [TBL] [Abstract][Full Text] [Related]  

  • 73. On the Chemical and Biological Characteristics of Multifunctional Compounds for the Treatment of Parkinson's Disease.
    García-Beltrán O; Urrutia PJ; Núñez MT
    Antioxidants (Basel); 2023 Jan; 12(2):. PubMed ID: 36829773
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Novel Therapeutics for the Treatment of Alzheimer's and Parkinson's Disease.
    Singh K; Yadav D; Chauhan PS; Mishra M; Jin JO
    Curr Pharm Des; 2020; 26(7):755-763. PubMed ID: 31914906
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Natural polyphenols effects on protein aggregates in Alzheimer's and Parkinson's prion-like diseases.
    Freyssin A; Page G; Fauconneau B; Rioux Bilan A
    Neural Regen Res; 2018 Jun; 13(6):955-961. PubMed ID: 29926816
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Targeting reactive oxygen species, reactive nitrogen species and inflammation in MPTP neurotoxicity and Parkinson's disease.
    Yokoyama H; Kuroiwa H; Yano R; Araki T
    Neurol Sci; 2008 Oct; 29(5):293-301. PubMed ID: 18941931
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Production of reactive oxygen species from aggregating proteins implicated in Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases.
    Tabner BJ; Turnbull S; El-Agnaf O; Allsop D
    Curr Top Med Chem; 2001 Dec; 1(6):507-17. PubMed ID: 11895127
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Neuroprotective Potential and Underlying Pharmacological Mechanism of Carvacrol for Alzheimer's and Parkinson's Diseases.
    Javed H; Mohamed Fizur NM; Jha NK; Ashraf GM; Ojha S
    Curr Neuropharmacol; 2023; 21(6):1421-1432. PubMed ID: 36567278
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Antidiabetic agents as a novel treatment for Alzheimer's and Parkinson's disease.
    Nowell J; Blunt E; Gupta D; Edison P
    Ageing Res Rev; 2023 Aug; 89():101979. PubMed ID: 37328112
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Aminoadamantanes: from treatment of Parkinson's and Alzheimer's disease to symptom amelioration of long COVID-19 syndrome?
    Müller T; Riederer P; Kuhn W
    Expert Rev Clin Pharmacol; 2023 Feb; 16(2):101-107. PubMed ID: 36726198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.